Jeff Yass’s IRulya Therapeutics IRLA Stock Holding History
Bought
Maintained
Sold
Other funds holding IRLA
SFCM
Jeff Yass's IRLA Position: Q2 2026 in Review
Jeff Yass sold out of IRulya Therapeutics (IRLA) in Q2 2026, closing a stake of 863 shares — an estimated $19.8K sold.
Jeff Yass first reported a position in IRLA in Q1 2021 and held it in 17 quarters. The position peaked at $6.12M in Q4 2021. 27 funds tracked by Wall St. Rank hold IRLA as of Q2 2026.
- Jeff Yass reported no remaining IRulya Therapeutics position as of Q2 2026 after selling out during the quarter.
- Jeff Yass sold 863 IRulya Therapeutics shares in Q2 2026, an estimated $19.8K.
- Jeff Yass first reported a position in IRulya Therapeutics in Q1 2021 and held it in 17 quarters.
- Jeff Yass's IRulya Therapeutics position peaked at $6.12M in Q4 2021.
- 27 funds tracked by Wall St. Rank held IRulya Therapeutics as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.